HCV Viral Load - Quantitative PCR

After initial HCV antibody testing, a positive HCV viral load confirms an active infection. This is important because not all individuals who have antibodies to HCV (indicating past exposure) have an ongoing infection.

Establishing a baseline viral load helps clinicians understand the severity of the infection and plan appropriate treatment strategies.

In the past, treatment decisions were sometimes based on viral load. Although newer treatments are more broadly applicable, knowing the viral load can still guide clinical decisions, such as the urgency of treatment. While most modern direct-acting antiviral (DAA) therapies are effective regardless of viral load, specific treatment regimens and durations may be influenced by the initial viral load.

While most modern direct-acting antiviral (DAA) therapies are effective regardless of viral load, specific treatment regimens and durations may be influenced by the initial viral load.

Sustained Virologic Response (SVR), defined as undetectable HCV RNA in the blood 12-24 weeks after completing therapy, is the goal of treatment. Achieving SVR is considered a cure for HCV infection, significantly reducing the risk of liver-related complications.

After treatment, monitoring viral load is essential to detect any potential relapse of the virus. An increase in viral load after an initial response can indicate treatment failure.

In patients at risk of HCV reinfection (e.g., those with ongoing risk factors like injection drug use), viral load testing can distinguish between relapse and a new infection.